Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase

被引：38

作者：

Ding, Y ^{[1
]}

Girardet, JL ^{[1
]}

Smith, KL ^{[1
]}

Larson, G ^{[1
]}

Prigaro, B ^{[1
]}

Lai, VCH ^{[1
]}

Zhong, WD ^{[1
]}

Wu, JZ ^{[1
]}

机构：

[1] Valeant Pharmaceut Int, Costa Mesa, CA 92626 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 03期

关键词：

HCV; inhibitor; NS5B; pteridine;

D O I：

10.1016/j.bmcl.2004.11.028

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

From compound library screening using an HCV NS5B RNA-dependent RNA polymerase enzymatic assay, we identified a pteridine hit compound with an IC50 of 15 muM. Our SAR studies were focused on the different groups at the 6- and 7-positions. substitutions at the 4-position, and replacement of N-1 or N-3 with carbon in the pteridine ring. We found that NH or OH at 4-position is critical for the inhibitory activity. Furthermore, a hydrophobic substituent at the 4-position may help compounds permeate through the cell membrane. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：675 / 678

页数：4

共 50 条

[21] Novel 4-Thiazolidinones as Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase
Cakir, Gizem
Kucukguzel, Ilkay
Guhamazumder, Rupa
Tatar, Esra
Manvar, Dinesh
Basu, Amartya
Patel, Bhargav A.
Zia, Javairia
Talele, Tanaji T.
Kaushik-Basu, Neerja
ARCHIV DER PHARMAZIE, 2015, 348 (01) : 10 - 22
[22] NS5B RNA Dependent RNA Polymerase Inhibitors: The Promising Approach to Treat Hepatitis C Virus Infections
Deore, R. R.
Chern, J. -W.
CURRENT MEDICINAL CHEMISTRY, 2010, 17 (32) : 3806 - 3826
[23] Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase
Munakata, T
Nakamura, M
Liang, YQ
Li, K
Lemon, SM
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (50) : 18159 - 18164
[24] Selection of 3′-template bases and initiating nucleotides by hepatitis C virus NS5B RNA-dependent RNA polymerase
Shim, JH
Larson, G
Wu, JZ
Hong, Z
JOURNAL OF VIROLOGY, 2002, 76 (14) : 7030 - 7039
[25] 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase
Hendricks, Robert T.
Spencer, Stacey R.
Blake, James F.
Fell, Jay B.
Fischer, John P.
Stengel, Peter J.
Leveque, Vincent J. P.
LePogam, Sophie
Rajyaguru, Sonal
Najera, Isabel
Josey, John A.
Swallow, Steven
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 410 - 414
[26] Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase
De Francesco, R
Tomei, L
Altamura, S
Summa, V
Migliaccio, G
ANTIVIRAL RESEARCH, 2003, 58 (01) : 1 - 16
[27] Inhibitors of the hepatitis C virus RNA-dependent RNA polymerase
Colarusso, Stefania
Attenni, Barbara
Avolio, Salvatore
Malancona, Savina
Harper, Steven
Altamura, Sergio
Koch, Uwe
Narjes, Frank
ARKIVOC, 2006, : 479 - 495
[28] Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase
Wu, JZ
Yao, NH
Walker, M
Hong, Z
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (12) : 1103 - 1112
[29] MEDI 334-Novel potent pyrazole based inhibitors of the HCV NS5B RNA-dependent RNA polymerase
Slater, Martin J.
Bravi, Gianpaolo
Cheasty, Anne G.
Corfield, John A.
Fenwick, Rebecca H.
Grimes, Richard M.
Harrison, David
Hartley, C. David
Jarvest, Richard L.
Medhurst, Katrina J.
Meeson, Malcolm L.
Mordaunt, Jacqueline E.
Mirzai, Fereshteh
Parry, Nigel R.
Shah, Pritom
Thommes, Pia A.
Wilkinson, Claire S.
Williams, Emily
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[30] Hepatitis C Virus RNA Replication Requires a Conserved Structural Motif within the Transmembrane Domain of the NS5B RNA-Dependent RNA Polymerase
Brass, Volker
Gouttenoire, Jerome
Wahl, Anja
Pal, Zsuzsanna
Blum, Hubert E.
Penin, Francois
Moradpour, Darius
JOURNAL OF VIROLOGY, 2010, 84 (21) : 11580 - 11584

← 1 2 3 4 5 →